ICER report: extended-release options for opioid use disorder News item 15 December 2018 Pages: 1 - 1
Production of chenodeoxycholic acid at university hospital legal News item 15 December 2018 Pages: 2 - 2
Access inequity for orphan medicinal products in EU countries Clinical study 15 December 2018 Pages: 3 - 3
Assessing opioid use and costs for cancer pain in the US Clinical study 15 December 2018 Pages: 7 - 7
Bacterial resistance imposes high cost burden on health insurance Clinical study 15 December 2018 Pages: 8 - 8
Being mindful of reducing cost in depression and anxiety Clinical study 15 December 2018 Pages: 10 - 10
Capecitabine + bevacizumab in CRC: small benefit, high cost in US Clinical study 15 December 2018 Pages: 11 - 11
Clopidogrel vs aspirin in acute coronary syndrome in China Clinical study 15 December 2018 Pages: 12 - 12
Comparing cost effectiveness of uterotonics for prevention of PPH Clinical study 15 December 2018 Pages: 13 - 13
Cost-effective tools for diagnosis of cutaneous leishmaniasis Clinical study 15 December 2018 Pages: 14 - 14
Cost-related insulin underuse in diabetic patients in USA Clinical study 15 December 2018 Pages: 15 - 15
Depot aripiprazole cost saving versus oral antipsychotics Clinical study 15 December 2018 Pages: 16 - 16
Generic drugs reduce expenditure, have no impact on utilisation Clinical study 15 December 2018 Pages: 17 - 17
Insecticidal interventions cost effective for malaria? Clinical study 15 December 2018 Pages: 18 - 18
Natriuretic-guided HF therapy: no QOL effect, higher cost Clinical study 15 December 2018 Pages: 19 - 19
Niraparib cost effective for recurrent ovarian cancer? Clinical study 15 December 2018 Pages: 20 - 20
Overuse of medical care common, with no benefit, potential harms Review 15 December 2018 Pages: 23 - 23
Patient and public involvement improves enrolment in trials Clinical study 15 December 2018 Pages: 24 - 24
Pembrolizumab reduces AEs, improves quality-adjusted survival Clinical study 15 December 2018 Pages: 25 - 25
Salpingectomy at cesarean cost effective for OvCa risk reduction Clinical study 15 December 2018 Pages: 28 - 28
Switch from Ferinject to Monofer reduces infusions and costs Clinical study 15 December 2018 Pages: 29 - 29
Talimogene laherparepvec plus ipilimumab not cost effective Clinical study 15 December 2018 Pages: 30 - 30
Transparency and consistency of economic evidence on vaccines Clinical study 15 December 2018 Pages: 32 - 32
What do Canadians value most for drug coverage decisions? Non-clinical study 15 December 2018 Pages: 33 - 33
Five new or amended cancer listings reimbursed in Australia News item 15 December 2018 Pages: 36 - 36
NICE recommends nivolumab for resected stage III and IV melanoma News item 15 December 2018 Pages: 38 - 38